10803-1-AP

antibody from Proteintech Group

Targeting: CD69 CLEC2C

Provider product page for 10803-1-AP

Western blot

ELISA

Immunocytochemistry

Immunohistochemistry

Antibody data

Antibody Data
Antigen structure
References [18]
Comments [0]
Validations
Western blot [1]

Submit

Product number: 10803-1-AP - Provider product page
Provider: Proteintech Group
Proper citation: Proteintech Cat#10803-1-AP, RRID:AB_2074965
Product name: CD69 antibody
Antibody type: Polyclonal
Description: CD69 antibody (Cat. #10803-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, WB,ELISA.
Reactivity: Human
Host: Rabbit
Conjugate: Unconjugated
Isotype: IgG
Vial size: 20ul, 150ul

CD69 protein structure - 10803-1-AP shown in red.

Submitted references Integrin-Mediated Mechanosensing of Modeled Lymph Node Microenvironment Promotes T Cell Activation via Nuclear Deformation.

Feng J, Zhao G, Zhao L, Geng L, Zhang S, Xu L, Liu M, Zhang G, Xu F, Lin M, Guo H
Research (Washington, D.C.) 2026;9:1121

CD20(+)FCRL4(+) B Cells Activate CD8(+) T Cells via MHC-I Restriction in Nasopharyngeal Carcinoma Anti-Tumor Immunity.

Zhang B, Yuan X, Gao K, You B, Wang Y, Meng L, Chen Z, Xie S, Liu Y, Dong Z, Xie S, Fan R, Wang F, Zhang J, Xie Z, Mo Y, Zhang H, Jiang W
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Mar;13(13):e14982

Single-cell and bulk transcriptomics reveal a CD8(+) T-cell gene signature predicting prognosis in diffuse large B-cell lymphoma.

Liu H, Feng Y, Qian Z, Song Z, Zhang N, Yu J, Liu X, Qiu L, Zhou S, Gong W, Meng B, Abolhassani H, Asghar M, Li L, He J, Zhang H, Wang X
Frontiers in immunology 2025;16:1685541

Integrating necroptosis and immune landscapes: a multi-omics-derived NecropImmScore stratifies prognosis and therapy in ovarian cancer.

Xu F, Kang S, Xu S
Cancer immunology, immunotherapy : CII 2025 Oct 15;74(11):340

Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy.

Logun M, Wang X, Sun Y, Bagley SJ, Li N, Desai A, Zhang DY, Nasrallah MP, Pai EL, Oner BS, Plesa G, Siegel D, Binder ZA, Ming GL, Song H, O'Rourke DM
Cell stem cell 2025 Feb 6;32(2):181-190.e4

A Comparative Analysis Dissecting the Immune Landscape of Vitiligo and Melanoma from a single-cell Perspective: Two Sides of the Same Coin?

Yu Y, Wang Y, Lu J, Cao X, Feng Y, Pei T, Lu Y
Inflammation 2025 Dec;48(6):4379-4397

NAD(+) Metabolism-Mediated SURF4-STING Axis Enhances T-Cell Anti-Tumor Effects in the Ovarian Cancer Microenvironment.

Shen J, Xu F, Liu T, Ye Y, Xu S
Cell death & disease 2025 Aug 23;16(1):640

Temporal resolved multi-proteomic analysis enabled the systematic characterization of N-glycosylation pattern changes during Jurkat T cell activation.

Dong M, Liu X, Zhao C, Fang Z, Wang Z, Guo X, Wang Y, Li Y, Ye M, Jia L
Analytical and bioanalytical chemistry 2025 Apr;417(10):2169-2183

Astragaloside IV augments anti-PD-1 therapy to suppress tumor growth in lung cancer by remodeling the tumor microenvironment.

Wu T, Wu S, Gao H, Liu H, Feng J, Yin G
European journal of histochemistry : EJH 2024 Oct 23;68(4)

The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms.

Chen Z, Lin S, Liang F, Hou Z, Yang Y, Huang H, Pan Y
Scientific reports 2024 Oct 21;14(1):24669

Targeting autophagy overcomes cancer-intrinsic resistance to CAR-T immunotherapy in B-cell malignancies.

Tang L, Zhang H, Zhou F, Wei Q, Du M, Wu J, Li C, Luo W, Zhou J, Wang X, Chen Z, Zhang Y, Huang Z, Wu Z, Wen Y, Jiang H, Liao D, Kou H, Xiong W, Mei H, Hu Y
Cancer communications (London, England) 2024 Mar;44(3):408-432

H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mTOR-CXCL1 axis.

Zhao Y, Jiang J, Zhou P, Deng K, Liu Z, Yang M, Yang X, Li J, Li R, Xia J
Biochemical pharmacology 2024 Apr;222:116120

Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis.

van Eijs MJM, Ter Linde JJM, Baars MJD, Amini M, Laclé MM, Brand EC, Delemarre EM, Drylewicz J, Nierkens S, Verheijden RJ, Oldenburg B, Vercoulen Y, Suijkerbuijk KPM, van Wijk F
iScience 2023 Oct 20;26(10):107891

An integrated bioinformatic investigation of focal adhesion-related genes in glioma followed by preliminary validation of COL1A2 in tumorigenesis.

Yao G, Deng L, Long X, Zhou Y, Zhou X
Aging 2023 Jun 22;15(13):6225-6254

Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair.

Zhao X, Fu L, Zou H, He Y, Pan Y, Ye L, Huang Y, Fan W, Zhang J, Ma Y, Chen J, Zhu M, Zhang C, Cai Y, Mou X
Journal of nanobiotechnology 2023 Jun 2;21(1):176

Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques.

Zheng H, Chen Y, Li J, Li H, Zhao X, Li J, Yang F, Li Y, Liu C, Qin L, Zuo Y, Zhang Q, He Z, Shi H, Li Q, Liu L
Cell reports 2022 May 24;39(8):110864

Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma.

Zhu C, Zou C, Guan G, Guo Q, Yan Z, Liu T, Shen S, Xu X, Chen C, Lin Z, Cheng W, Wu A
Oncoimmunology 2019;8(9):e1621677

Juxtaposition of IL-1β and IFN-γ expression and apoptosis of keratinocytes in adult-onset Still's disease.

Rao S, Li Q, Wu H, Zhao M, Wang A, Zhang G, Li J, Lu L, Shi W, Lu Q
Expert review of clinical immunology 2019 Dec;15(12):1341-1350

No comments: Submit comment

Supportive validation

Submitted by: Proteintech Group (provider)
Main image
Experimental details: The CD69 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CD69. This antibody recognizes human antigen. The CD69 antibody has been validated for the following applications: ELISA, WB analysis.
Appendix: 10803-1-AP.pdf

: Show more